Study of Correlation between Diabetic Pulmonopathy with Serum Adiponectin Levels in Patients of Type 2 Diabetes Mellitus.

Study of Correlation between Diabetic Pulmonopathy with Serum Adiponectin Levels in Patients of Type 2 Diabetes Mellitus. J Assoc Physicians India. 2018 Oct;66(10):11-12 Authors: Kumar S, Gupta A, Sameja P, Patel I, Gupta S Abstract Diabetes mellitus a disease with various macro and micro vascular complications due to its various metabolic dysregulations, is well known to involve lungs in long run in both type 1 and 2 diabetes mellitus, causing tremendous burden on health care system. Common simple lung function tests alone are likely to underestimate the prevalence and degree of lung dysfunction in diabetes, but newer noninvasive tests of lung mechanical function provide a more sensitive assessment of peripheral airway function, hence by establishing a marker and risk factors for pulmonary involvement in diabetic individuals, cases with high risk for pulmonary involvement can be found before hand and proper medical therapy can be started for primary prophylaxis of same, Hence in this study we tried to find out any correlation between serum adiponectin levels and pulmonary dysfunction in patients of type 2 diabetes mellitus, which shows a significant role of adiponectin as early marker of the disease with p value of 0.04, the decrease in serum adiponectin level is also associated with more severe disease, hence adiponectin levels can be used as early markers of pulmonary dysfunction in diabetic patients. PMID: 31317704 [PubMed - in process]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research

Related Links:

Long-acting basal insulins are used for the management of both type 1 and type 2 diabetes mellitus. Long-acting basal insulins were developed utilizing recombinant DNA technology and have been available since 2000 with the approval of insulin glargine U-100 followed by insulin detemir in 2005. In recent years, diabetes management has become more complex with the approval of insulin glargine U-300 and insulin degludec U-100 and U-200. Both insulin glargine U-300 and insulin degludec have been compared with insulin glargine U-100 and have demonstrated longer durations of action, as well as lower rates of hypoglycemia. This r...
Source: Cardiology in Review - Category: Cardiology Tags: New Therapy Source Type: research
ski G Abstract BACKGROUND: The prevalence of pancreatic exocrine insufficiency (PEI) in diabetes mellitus (DM) varies widely between studies, which may be explained by methodological problems. We aimed to establish the prevalence of PEI in DM using the faecal elastase-1 (FE-1) assay as a screening test, and to further investigate these patients by the mixed 13C-triglyceride (13C-MTG) breath test. METHODS: One hundred and thirty-three consecutive type 1 or type 2 DM patients without known exocrine pancreatic disorders were recruited. Demographic parameters, stool consistency, stool frequency, routine laborator...
Source: European Journal of Internal Medicine - Category: Internal Medicine Authors: Tags: Eur J Intern Med Source Type: research
Conclusion: These findings suggested that increased serum levels of miR-154-5p and decreased OC levels may influence osteogenesis and proteinuria in T2DM and may identify novel targets for diagnosis and treatment of diabetic kidney disease and osteoporosis.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
The present study has the objective to assess the zinc (Zn), copper (Cu), and oxysterols plasma levels in type 1 (DM1) (n=26) and type 2 (DM2) (n=80) diabetes patients, as compared to healthy controls (n=71), in order to testify whether metal levels may have a significant impact on the association between oxysterols and diabetes.
Source: Clinical Nutrition - Category: Nutrition Authors: Tags: Original article Source Type: research
AbstractBackgroundPrevious studies showed altered angiopoietin-like protein-8 (ANGPTL-8) circulating levels in type 2 diabetes mellitus (DM). Whether or not the alteration in ANGPTL-8 level can be a predictive maker for increased DM risk remains unclear.AimInvestigating possible role of ANGPTL-8 as a risk predictor of type2 DM, in addition to a set of factors likely to affect ANGPTL-8 level.MethodsOne hundred recently diagnosed persons with type 2 DM and 100 sex- and age-matched healthy controls were enrolled. Exclusion criteria included type 1 DM, acute infections, history of chronic kidney disease, malignancy, and blood ...
Source: EPMA Journal - Category: International Medicine & Public Health Source Type: research
Background and Aims: Diabetes has been associated with an increased cardiovascular disease (CVD) risk. Serum apolipoprotein (apo) B is an independent risk factor for CVD, both in diabetic and non-diabetic subjects. In the latter, high circulating erythrocyte-bound apoB (ery-apoB) has been associated with protection against atherosclerosis. We aimed to evaluate ery-apoB in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM).
Source: Atherosclerosis - Category: Cardiology Authors: Tags: Posters 26 - 29 May, 2019 Source Type: research
Discovery and Biological Evaluation of Potent and Orally Active Human 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Type 2 Diabetes Mellitus. Chem Pharm Bull (Tokyo). 2019;67(8):824-838 Authors: Koike T, Shiraki R, Sasuga D, Hosaka M, Kawano T, Fukudome H, Kurosawa K, Moritomo A, Mimasu S, Ishii H, Yoshimura S Abstract We synthesized and evaluated novel 5-[2-(thiophen-2-yl)propan-2-yl]-4H-1,2,4-triazole derivatives as 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors. Optimization of the thiophene ring and the substituents on the 1,2,4-triazole ring...
Source: Chemical and Pharmaceutical Bulletin - Category: Drugs & Pharmacology Authors: Tags: Chem Pharm Bull (Tokyo) Source Type: research
Background and Aims: Significant associations between IgG glycans and kidney function in type 1 diabetes and nondiabetic individuals have been described. IgG glycans may also have biomarker potential for the course of kidney function in type 2 diabetes. We investigated the prospective relation between IgG N-glycosylation and kidney function in T2D.
Source: Atherosclerosis - Category: Cardiology Authors: Tags: E-poster session Source Type: research
CONCLUSIONS: Hyperhomocysteinemia potentiated systemic and vessel wall inflammation and vascular dysfunction partially via inflammatory monocyte subset induction in T2DM. Inflammatory monocyte may be a novel therapeutic target for insulin resistance, inflammation, and cardiovascular complications in hyperhomocysteinemia+T2DM. PMID: 31366217 [PubMed - as supplied by publisher]
Source: Arteriosclerosis, Thrombosis and Vascular Biology - Category: Cardiology Authors: Tags: Arterioscler Thromb Vasc Biol Source Type: research
This study aimed to assess islet insulin secretion and insulin resistance in Chinese patients with latent autoimmune diabetes in adults (LADA).MethodsTwelve patients with LADA, 10 with type 1 diabetes mellitus (T1DM), 10 with type 2 diabetes mellitus (T2DM), and 10 nondiabetic healthy controls (HCs) were included. Patients with LADA were subtyped according to the glutamic acid decarboxylase antibody (GADA) titer (LADA1, GADA titer  ≥ 180 U/mL; LADA2, GADA titer 18–180 U/mL). Insulin secretion and sensitivity were assessed using hyperglycemic and hyperinsulinemic–euglycemic clamp tests, respec...
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | General Medicine | Health Management | India Health | Study